CSPC Pharmaceutical Group Limited (CVG) — Cash Flow-to-Debt Ratio
CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow-to-Debt Ratio of 0.25x as of June 2020, meaning its operating cash flow of €2.16 Billion could theoretically repay 0% of its total liabilities (€8.46 Billion) in one year. See CSPC Pharmaceutical Group Limited free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CSPC Pharmaceutical Group Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for CSPC Pharmaceutical Group Limited across 13 annual periods. For the full cash flow conversion analysis, see CSPC Pharmaceutical Group Limited (CVG) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year debt coverage analysis for CSPC Pharmaceutical Group Limited. Check CSPC Pharmaceutical Group Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | €5.83 Billion | €12.15 Billion | ▲ +11.4% |
| 2024 | 0.43x | €4.53 Billion | €10.52 Billion | ▲ +16.2% |
| 2023 | 0.37x | €4.18 Billion | €11.26 Billion | ▼ -50.7% |
| 2022 | 0.75x | €7.63 Billion | €10.13 Billion | ▲ +28.5% |
| 2021 | 0.59x | €4.64 Billion | €7.91 Billion | ▼ -39.4% |
| 2020 | 0.97x | €6.74 Billion | €6.97 Billion | ▲ +73.8% |
| 2019 | 0.56x | €3.78 Billion | €6.80 Billion | ▲ +12.5% |
| 2018 | 0.49x | €3.80 Billion | €7.67 Billion | ▼ -22.9% |
| 2017 | 0.64x | €3.29 Billion | €5.13 Billion | ▼ -10.0% |
| 2016 | 0.71x | €2.92 Billion | €4.09 Billion | ▲ +49.8% |
| 2015 | 0.48x | €2.25 Billion | €4.73 Billion | ▲ +14.6% |
| 2014 | 0.42x | €1.81 Billion | €4.35 Billion | ▲ +134.6% |
| 2013 | 0.18x | €814.86 Million | €4.60 Billion | — |